mr BRIAN MEYER

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the OIG on Compendia . Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTC on biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance Patient Treatment Act.

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the GAO on compounding. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTCon biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance patient Treatment Act.

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the OIG on Compendia . Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTC on biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance Patient Treatment Act.

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and Part D formulary issues. Support for H.R. 4190, a bill that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program.

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Support for HR 4190, a bill that would amend Title 18 of the Social Security Act to provide for coverage under the Medicare Program of pharmacist services.

Contact concerning FDA authority to manage drug shortages and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication with the FDA on the REMS program. Contact concerning S. 959, Pharmaceutical Compounding and Quality Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning HR 3204 (all sections) the Drug Quality and Security Act.

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the FDA on the REMS program. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles.

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Communication with the Office of the Inspector General regarding Conflicts of Interest for Compendia recognized by Medicare. Support for Grassley/Carper Amendment #7 to the SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871), which would list pharmacists as providers within Accountable Care Organizations.

Contact concerning FDA authority to manage drug shortages, and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication to DEA on central fill of controlled substances. Contact concerning S. 959, Pharmaceutical Compounding and Quality and Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning S. 957, Drug Supply Chain Security Act, (all sections) to track and trace drug products.

Contact concerning FDA authority to manage drug shortages and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication with the FDA on the REMS program. Contact concerning S. 959, Pharmaceutical Compounding and Quality Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning HR 3204 (all sections) the Drug Quality and Security Act.

Contact concerning FDA authority to manage drug shortages, and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication to DEA on central fill of controlled substances. Contact concerning S. 959, Pharmaceutical Compounding and Quality and Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning S. 957, Drug Supply Chain Security Act, (all sections) to track and trace drug products.

H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.

H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.

S. 3187, H.R. 5651, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars, drug safety, expansion of over the counter (OTC) medicines. Communications to Health Resources and Services Administration on 340B drug discount program.

H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."

S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.

H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."

H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Admnistration (FDA) authority to manage drug shortages. Communication to FDA on withdrawal of unapproved drugs, presentation at FDA Public Workshop on drug shortages. Labor-Health and Human Services appropriations, fiscal year 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of the Affordable Care Act (P.L. 111-148)

H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on dietary supplements, long-acting opiods, Prescription Drug User Fee Act presentation at FDA public meeting. Communications with the National Institute for Occupational Safety and Health (NIOSH) on their proposed list of hazardous drugs for 2012. Support for S. 1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authority.

Comments to the Health Resources and Services Administration on the 340B Drug Discount Program and the procurement of orphan drugs under the program. Submitted letter of support for H.R. 2674, the 340B Improvement Act of 2011.

H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to the FDA on Medication guideline distribution and the REMS program, drug shortages. Labor-Health and Human Services appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (P.L. 111-148). Communication to the Office of the National Coordinator for Health Information Technology regarding its strategic plan. Communication to Office of Management and Budget concerning consumer medication information.

S. 296, Preserving Access to Life-Saving Medications Act, all provisions. Contacts concerning Food and Drug Admnistration (FDA)authority to manage drug shortages. Communication to Office of the National Coordinator for Health Information Technology regarding meaningful use implementation. Labor-Health and Human Services Appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (PL 111-148). Communication to repeal IRS form 1099 reporting provision in Affordable Care Act. S. 48, Pharmacist Student Loan Repayment Eligibility Act, all provisions.

H.R. 5389, The Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010, all provisions. Communications to Environmental Protection Agency on Draft Guidances for Best Management Practices for Unused Pharmaceuticals at Health Care Facilities; Pharmaceutical Waste. Communications to Food and Drug Administration (FDA) on Bar Code Label Requirements; Development and Distribution of Patient Medication Information for Prescription Drugs; and Generic Drug User Fees. Communications to FDA on Distribution of Medication Guide as part of Risk Evaluation and Mitigation Strategies; Approval Pathway for Biosimilars. Communication to Drug Enforcement Administration on Placement of Propofol into Schedule IV Controlled Substance.

Supported HR 5389, "Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010," all provisions. Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." Communication to HHS regarding strategic framework on multiple chronic conditions; Communication to FDA on direct-to-consumer prescription drug advertisements; Meeting with AHRQ to discuss comparative effectiveness research.

Communications with Food and Drug Admnistration on Risk Evaluation and Mitigation Strategies, reauthorization of the Prescription Drug User Fee Act, medical product recalls, experimental study of patient information prototypes and patient medication information, drug shortages, and generic drug user fees. Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. HR 5389, The Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010, all provisions.

Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. S. 3690, Drug Safety and Accountability Act of 2010, all provisions. H.R.6543, Drug Safety Enhancement Act of 2011. Contacts concerning Food and Drug Administration authority to manage drug shortages. Contacts concerning funding for section 3503 of H.R. 3590, Patient Protection and Affordable Care Act.

Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. S. 3690, Drug Safety and Accountability Act of 2010, all provisions. H.R.6543, Drug Safety Enhancement Act of 2011. Contacts concerning Food and Drug Administration authority to manage drug shortages. Contacts concerning funding for section 3503 of H.R. 3590, Patient Protection and Affordable Care Act.

Labor-Health and Human Services Apprpriations fiscal years 2010 and 2011. S. 3690, Drug Safety and Accountability Act of 2010 all provisions. Communication with FDA on the judicious use of medically important antimicrobial drugs in food-producing animals, and the Safe Use Initiative. Communications to Agency for Healthcare Research and Quality regarding comparative effectiveness.

Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." H.R. 3962, Affordable Health Care for America Act, Title II, all provisions relating to Frontline Health Providers and Loan Forgiveness; Title III, all provisions relating to "medical home" and "independence at home;" Title V, all provisions relating to "medication therapy management." Communications to House and Senate supporting residency funding. Communicatins with FDA regarding the Safe Use Initiative; Communications with FDA regarding inpatient distribution of Medication Guides; Communication with FDA on Transparency Task Force; Communication with FDA on appointment of Special Government Employees.

Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. S. 3690, Drug Safety and Accountability Act of 2010, all provisions. H.R.6543, Drug Safety Enhancement Act of 2011. Contacts concerning Food and Drug Administration authority to manage drug shortages. Contacts concerning funding for section 3503 of H.R. 3590, Patient Protection and Affordable Care Act.

Labor-Health and Human Services Appropriations fiscal years 2010 and 2011. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." H.R. 3962, Affordable Health Care for America Act, Title II, all provisions relating to Frontline Health Providers and Loan Forgiveness; Title III, all provisions relating to "medical home" and "independence at home;" Title V, all provisions relating to "medication therapy management." Communications to House and Senate supporting residency funding. Communicatins with FDA regarding the Safe Use Initiative; Communications with FDA regarding inpatient distribution of Medication Guides; Communication with FDA on Transparency Task Force; Communication with FDA on appointment of Special Government Employees.

FDA Appropriations FY10. Communication to White House Office on Health Care Reform. Letter and support for HR 2891, Access to Frontline Health Care Act of 2009, all provisions dealing with loan forgiveness for Title VII health professions. Testimony to House Energy and Commerce Committee on HR 3200, support second year specialized residency programs and medication therapy management grant program. Letters to Senate Finance Committee on residency funding.

FDA Appropriations FY10. Communication to White House Office on Health Care Reform. Support for HR 2891, Access to Frontline Health Care Act of 2009, all provisions. Support for S 245, Retooling the Healthcare Workforce for an Aging America Act of 2009. Letter urging funding for residency programs in America's Affordable Health Choices Act, HR 3200. Statement to Senate Finance Committee on Healthcare Reform Delivery Options and Coverage Options. Statement to Senate Finance Committee on workforce. Statement to House Energy and Commece Committee on Health Reform. Letters to Senate Finance and Ways and Means Committees on residency funding. Communication with Congressional Budget Office on heatlh care reform. Communication with FDA regarding market withdrawal of morphine sulphate oral solution. Communicatin with FDA on Risk Evaluation and Mititgation Strategies for certain opioid drugs. Communication with NIOSH regarding additions and deltions to hazardous drug list. Communication with FDA regarding safety of acetaminophen-containing drug products.

FDA Appropriations FY10. Communication to White House Office on Health Care Reform. Letter and support for HR 2891, Access to Frontline Health Care Act of 2009, all provisions dealing with loan forgiveness for Title VII health professions. Testimony to House Energy and Commerce Committee on HR 3200, support second year specialized residency programs and medication therapy management grant program. Letters to Senate Finance Committee on residency funding.

FDA Appropriations FY10. Communication to White House Office on Health Care Reform. Support for HR 2891, Access to Frontline Health Care Act of 2009, all provisions. Support for S 245, Retooling the Healthcare Workforce for an Aging America Act of 2009. Letter urging funding for residency programs in America's Affordable Health Choices Act, HR 3200. Statement to Senate Finance Committee on Healthcare Reform Delivery Options and Coverage Options. Statement to Senate Finance Committee on workforce. Statement to House Energy and Commece Committee on Health Reform. Letters to Senate Finance and Ways and Means Committees on residency funding. Communication with Congressional Budget Office on heatlh care reform. Communication with FDA regarding market withdrawal of morphine sulphate oral solution. Communicatin with FDA on Risk Evaluation and Mititgation Strategies for certain opioid drugs. Communication with NIOSH regarding additions and deltions to hazardous drug list. Communication with FDA regarding safety of acetaminophen-containing drug products.

FDA Appropriations FY10. Communication to White House Office on Health Care Reform. Support for HR 2891, Access to Frontline Health Care Act of 2009, all provisions. Support for S 245, Retooling the Healthcare Workforce for an Aging America Act of 2009. Letter urging funding for residency programs in America's Affordable Health Choices Act, HR 3200. Statement to Senate Finance Committee on Healthcare Reform Delivery Options and Coverage Options. Statement to Senate Finance Committee on workforce. Statement to House Energy and Commece Committee on Health Reform. Letters to Senate Finance and Ways and Means Committees on residency funding. Communication with Congressional Budget Office on heatlh care reform. Communication with FDA regarding market withdrawal of morphine sulphate oral solution. Communicatin with FDA on Risk Evaluation and Mititgation Strategies for certain opioid drugs. Communication with NIOSH regarding additions and deltions to hazardous drug list. Communication with FDA regarding safety of acetaminophen-containing drug products.

S. 252, Veterans Health Care Authorization of 2009, Title I, all provisions relating to incentive pay for pharmacists. Communications with FDA regarding Risk Evaluation and Mitigation Strategies, Medication Guides, and providing effective information to consumers about prescription drug risks and benefits. Communication with DEA regarding the identification of institution-based individual practitioners.

FDA Appropriations FY10. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." H.R. 3962, Affordable Health Care for America Act, Title II, all provisions relating to Frontline Health Providers and Loan Forgiveness; Title III all provisions relating to "medical home" and "independence at home;" Title V, all provisions relating to "medication therapy management." Communcations to House and Senate supporting residency funding. Communication with FDA on market withdrawal of unapproved nitroglycerin.

FDA Appropriations FY10. H.R. 3590, Patient Protection and Affordable Care Act, Title III, all provisions relating to "medication therapy management," "medical home," and "independence at home." H.R. 3962, Affordable Health Care for America Act, Title II, all provisions relating to Frontline Health Providers and Loan Forgiveness; Title III all provisions relating to "medical home" and "independence at home;" Title V, all provisions relating to "medication therapy management." Communcations to House and Senate supporting residency funding. Communication with FDA on market withdrawal of unapproved nitroglycerin.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

Ambulatory Payment Classification (APC) Panel testimony and comments. APC Panel Nomination. Letters to CMS and CMS officials regarding compendia additions and deletions including American Hospital Formulary Service-Drug Information. Comments relating to electronic prescribing under Part D. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management. HR 3162, Children's Health and Medicare Protection Act (CHAMP Act), provisions on comparative effectiveness research. Recognition of pharmacists as health care providers and payment for clinical services. Recognition of AHFS as drug compendia for coverage of unlabeled uses. Funding for specialized pharmacy residency programs. Electronic prescribing.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

S. 901, Health Centers Renewal Act of 2007 and S.2708, Caring for an Aging America Act of 2008. Include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2932, Poison Center Support, Enhancement, and Awareness Act of 2008 support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. Comments relating to standards and technologies for numerical identifier, validation, track and trace, and authentication for prescription drugs. Comments on Direct-to-Consumer Advertising. Comments on proposed National Institute for Occupational Safety and Health survey of healthcare workers' safety and health. Meetings with HRSA officials on general and common issues on pharmacy technicians, telepharmacy, loan forgiveness.

S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I, Section 182, Provision that revises definition of medically accepted indication for drugs and conflic of interest. Comments on proposed changes to the Hospital Inpatient Prospective Payment Systems and FY 2009 Rates-Proposed Rule.

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I, Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation & written testimony before CMS Ambulatory Payment Classification Panel regarding pharmacy overhead. Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 payment rates and 340B Drug Pricing Program. Communications with CMS re:Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Communications with CMS re: billing for pharmacist services in hospital-based anticoagulation clinics.

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, Title I Section 182, provision that revises definition of medically accepted indication for drugs and conflicts of interest. Communication and meetings with CMS staff regarding compendia recognition. Presentation and written testimony before CMS' Ambulatory Payment Classification Panel regarding pharmacy overhead Comments to CMS re: Hospital Outpatient Prospective Payment System and 2009 Payment rates. Communications with CMS re: Conditions of Participation and Interpretive Guidance regarding standing orders and protocols. Comments to CMS re: e-prescribing exemption for computer generated facsimile transmissions.

Ambulatory Payment Classification (APC) Panel testimony and comments. APC Panel Nomination. Letters to CMS and CMS officials regarding compendia additions and deletions including American Hospital Formulary Service-Drug Information. Comments relating to electronic prescribing under Part D. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management. HR 3162, Children's Health and Medicare Protection Act (CHAMP Act), provisions on comparative effectiveness research. Recognition of pharmacists as health care providers and payment for clinical services. Recognition of AHFS as drug compendia for coverage of unlabeled uses. Funding for specialized pharmacy residency programs. Electronic prescribing.

S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.

S. 901, Health Centers Renewal Act of 2007 and S.2708, Caring for an Aging America Act of 2008. Include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2932, Poison Center Support, Enhancement, and Awareness Act of 2008 support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. Comments relating to standards and technologies for numerical identifier, validation, track and trace, and authentication for prescription drugs. Comments on Direct-to-Consumer Advertising. Comments on proposed National Institute for Occupational Safety and Health survey of healthcare workers' safety and health. Meetings with HRSA officials on general and common issues on pharmacy technicians, telepharmacy, loan forgiveness.

S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.

S. 901, Health Centers Renewal Act of 2007 and S.2708, Caring for an Aging America Act of 2008. Include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2932, Poison Center Support, Enhancement, and Awareness Act of 2008 support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. Comments relating to standards and technologies for numerical identifier, validation, track and trace, and authentication for prescription drugs. Comments on Direct-to-Consumer Advertising. Comments on proposed National Institute for Occupational Safety and Health survey of healthcare workers' safety and health. Meetings with HRSA officials on general and common issues on pharmacy technicians, telepharmacy, loan forgiveness.

S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.

S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.

S.901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the Natinal Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pharmacist. S.2932, Poison Center Support, Enhancement and Awareness Act of 2008, support all provisions. Communication to FDA on NDC number.

Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.

S. 901, Health Centers Renewal Act of 2007 and S.2708, Caring for an Aging America Act of 2008. Include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2932, Poison Center Support, Enhancement, and Awareness Act of 2008 support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. Comments relating to standards and technologies for numerical identifier, validation, track and trace, and authentication for prescription drugs. Comments on Direct-to-Consumer Advertising. Comments on proposed National Institute for Occupational Safety and Health survey of healthcare workers' safety and health. Meetings with HRSA officials on general and common issues on pharmacy technicians, telepharmacy, loan forgiveness.

S. 901, Health Centers Renewal Act of 2007, include pharmacists as eligible for loan forgiveness programs of the National Health Service Corps. S.2708, Caring for an Aging America Act of 2008, include pharmacists in geriatric training program. Proposed legislation to create an academic counterdetailing program on prescription drugs. Outlined potential role of the pahrmacist. S. 2932, Poison Center Support, Enhancement, and Awareness of 2008, support all provisions. H.R. 5491, The Pharmacy Technician Training and Registration Act of 2008; all provisions. FDA: Communicated policy concerning National Drug Code number system and need for improvements. DEA: proposed rule concerning electronic prescriptions for controlled substances. Comments to the Office of the Natinal Coordinator for Health Information Technology re: Draft Medication Gaps and Draft Order Sets.

H.R. 2642, Iraq War Supplemental Appropriations, support additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; Risk Communication Advisory Committee meeting; maintaining HFA designation on labeling. Meeting with FDA Chief of Staff; Communication to FDA re: testimony before joint meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Comments to FDA re concept paper on evaluating proposed drug name submissions. Comments to FDA on content and format labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling; Communication re; nominations to FDA advisory committee

H.R.2642, Iraq War Supplemental Appropriations, additional appropriations for Food and Drug Administration. Communications to FDA staff regarding gluten labeling on medications; nominations to FDA Advisory Committees;MedWatch Partners and electronic data collection; Best Practices for Distribution of Antivirals for Pandemic Influenza: Public Health Impact and Research Recommendations. Communication with FDA concerning the phased removal of propoxyphene from the market.

H.R. 2642, Iraq War Supplemental Appropriations, support additional appropriations for Food and Drug Administration. Comments on Draft Guidance for Industry on Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unaproved new Uses of Approved Drugs and Approved or Cleared Medical Devices. Comments on Draft Prescription Drug User Fee Act IV Drug Safety Five-Year Plan; Communications to FDA staff regarding request for feedback on FDA's unapproved drug initiative. Communication with FDA staff regarding behind-the-counter availability of certain drugs. Comments on Patient Safety and Quality Improvement-Notice of Proposed Rulemaking. Nominations to National Advisory Council for Healthcare Research and Quality. Comments on designation of Medically Underserved Populations and Health Professional Shortage Areas Notice of Proposed Rulemaking.

Ambulatory Payment Classification (APC) Panel testimony and comments. APC Panel Nomination. Letters to CMS and CMS officials regarding compendia additions and deletions including American Hospital Formulary Service-Drug Information. Comments relating to electronic prescribing under Part D. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management. HR 3162, Children's Health and Medicare Protection Act (CHAMP Act), provisions on comparative effectiveness research. Recognition of pharmacists as health care providers and payment for clinical services. Recognition of AHFS as drug compendia for coverage of unlabeled uses. Funding for specialized pharmacy residency programs. Electronic prescribing.

HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisions. S.901, Reauthorization of National Health Service Corps, provisions relating to loan forgiveness programs. Funding for Food and Drug Admnistration. HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR1038, Access to Life Saving Medicine Act, provisions dealing with interchangability. Proposal by FDA for a behind the counter drug category (public meeting and comments). Electronic

HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisions. S.901, Reauthorization of National Health Service Corps, provisions relating to loan forgiveness programs. Funding for Food and Drug Admnistration. HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR1038, Access to Life Saving Medicine Act, provisions dealing with interchangability. Proposal by FDA for a behind the counter drug category (public meeting and comments). Electronic

Requirement to report National Drug Code Number to State Medicaid agencies (provision in Deficit Reduction Act.) H.R. 3090, provision delaying date requiring tamper resistant prescriptions. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management.

Requirement to report National Drug Code Number to State Medicaid agencies (provision in Deficit Reduction Act.) H.R. 3090, provision delaying date requiring tamper resistant prescriptions. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management.

HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisions. S.901, Reauthorization of National Health Service Corps, provisions relating to loan forgiveness programs. Funding for Food and Drug Admnistration. HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR1038, Access to Life Saving Medicine Act, provisions dealing with interchangability. Proposal by FDA for a behind the counter drug category (public meeting and comments). Electronic

Requirement to report National Drug Code Number to State Medicaid agencies (provision in Deficit Reduction Act.) H.R. 3090, provision delaying date requiring tamper resistant prescriptions. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management.

HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisions. S.901, Reauthorization of National Health Service Corps, provisions relating to loan forgiveness programs. Funding for Food and Drug Admnistration. HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR1038, Access to Life Saving Medicine Act, provisions dealing with interchangability. Proposal by FDA for a behind the counter drug category (public meeting and comments). Electronic